Cellmid Ltd
ASX:CDY
Cellmid Ltd
ASX:CDY
Price:
0.054
AUD
8%
Market Cap:
AU$11.9m
Balance Sheet
Balance Sheet Decomposition
Cellmid Ltd
Cellmid Ltd
Balance Sheet Decomposition is not available for
Cellmid Ltd
Cellmid Ltd
Balance Sheet
Cellmid Ltd
Cellmid Ltd
Currency: AUD
| Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
2
|
3
|
2
|
3
|
4
|
2
|
3
|
7
|
7
|
|
| Cash |
1
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
2
|
3
|
4
|
2
|
3
|
7
|
7
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
2
|
2
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
2
|
2
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
2
|
2
|
2
|
1
|
1
|
1
|
2
|
3
|
3
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
4
|
5
|
4
|
4
|
6
|
4
|
7
|
12
|
11
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Intangible Assets |
0
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
3
N/A
|
6
+138%
|
6
+8%
|
6
-5%
|
7
+16%
|
8
+15%
|
7
-17%
|
10
+45%
|
15
+52%
|
13
-11%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
1
|
1
|
2
|
2
|
0
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
|
| Total Current Liabilities |
0
|
1
|
1
|
2
|
2
|
4
|
4
|
3
|
4
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+61%
|
1
+20%
|
2
+200%
|
3
+15%
|
4
+50%
|
5
+20%
|
4
-20%
|
5
+29%
|
3
-44%
|
|
| Equity | |||||||||||
| Common Stock |
21
|
25
|
27
|
29
|
32
|
37
|
38
|
48
|
56
|
60
|
|
| Retained Earnings |
19
|
20
|
22
|
25
|
28
|
33
|
36
|
42
|
47
|
50
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Equity |
2
N/A
|
5
+154%
|
6
+6%
|
4
-33%
|
4
+16%
|
4
-7%
|
2
-54%
|
6
+216%
|
10
+67%
|
10
+6%
|
|
| Total Liabilities & Equity |
3
N/A
|
6
+138%
|
6
+8%
|
6
-5%
|
7
+16%
|
8
+15%
|
7
-17%
|
10
+45%
|
15
+52%
|
13
-11%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
26
|
33
|
37
|
40
|
50
|
58
|
61
|
90
|
135
|
201
|
|
Switch to:
Switch to:
See Also
Discover More
